-
公开(公告)号:AU3138784A
公开(公告)日:1985-02-07
申请号:AU3138784
申请日:1984-08-01
Applicant: MILES LAB
Inventor: CARRICO ROBERT J , DERIEMER LESLIE H , GROSCH JOSEPHINE C , WILSON GARY A
-
公开(公告)号:DK591484D0
公开(公告)日:1984-12-11
申请号:DK591484
申请日:1984-12-11
Applicant: MILES LAB
Inventor: ALBARELLA JAMES P , ANDERSON LESLIE H , CARRICO ROBERT J
-
公开(公告)号:FI844869A0
公开(公告)日:1984-12-10
申请号:FI844869
申请日:1984-12-10
Applicant: MILES LAB
Inventor: ALBARELLA JAMES P , ANDERSON LESLIE H , CARRICO ROBERT J
-
公开(公告)号:DK568684D0
公开(公告)日:1984-11-29
申请号:DK568684
申请日:1984-11-29
Applicant: MILES LAB
Inventor: BLAKE DIANE A , BOGUSLASKI ROBERT C , CARRICO ROBERT J , SKARSTEDT MARK T
IPC: G01N33/535 , G01N33/542 , G01N33/58 , C12Q
-
公开(公告)号:DK488682A
公开(公告)日:1983-05-05
申请号:DK488682
申请日:1982-11-03
Applicant: MILES LAB
Inventor: ATKINSON DAVID C , CARRICO ROBERT J , MORRIS DAVID L
Abstract: An improved immunoassay method, reagent means, and test kit for determining an iodothyronine, e.g., thyroxine (T-4), in a biological fluid, usually serum or piasma, wherein fenclofenac and related phenylacetic acids, or salts thereof, are employed as novel blocking agents for the binding of iodothyronines to thyroxine binding protein (TBP). The present invention is particularly advantageous as applied to homogeneous competitive binding iodothyronine immunoassays wherein a spectrophotometric response is generated in the assay reaction mixture at a wavelength greater than about 300 nm, the blocking agents of the present invention having been found to have no substantial absorbance at wavelengths above 300 nm. Such homogeneous immunoassays include those which employ labels such as fluorescers, enzyme substrates, enzyme prosthetic groups, enzymes, and enzyme inhibitors.
-
公开(公告)号:CA1133392A
公开(公告)日:1982-10-12
申请号:CA341540
申请日:1979-12-10
Applicant: MILES LAB
Inventor: BOGUSLASKI ROBERT C , CARRICO ROBERT J
IPC: G01N21/76 , G01N33/533 , G01N33/536 , G01N33/543 , G01N33/52
Abstract: A specific binding assay method and reagent means for determining a ligand, such as an antigen or antibody, in, or the ligand binding capacity of, a liquid medium which employs a fluorescent substance, i.e. a fluorescer, as a label. The improvement comprises measuring the fluorescer-label by chemically exciting the label and measuring the resulting light emitted thereby. Chemical excitation of the label is preferably accomplished by exposure to a substance, such as a high energy intermediate produced by the reaction between hydrogen peroxide and highly reactive materials such as oxalyl chloride, oxamides and bis-oxalate esters. The assay may follow conventional homogeneous and heterogeneous formats. The improved assay is more convenient than conventional fluorescent binding assays by obviating the need for photogenic excitation of the fluorescent label.
-
公开(公告)号:CA1079632A
公开(公告)日:1980-06-17
申请号:CA288598
申请日:1977-10-13
Applicant: MILES LAB
Inventor: BOGUSLASKI ROBERT C , CARRICO ROBERT J , CHRISTNER JAMES E
IPC: G01N33/536 , G01N33/50 , G01N33/53 , G01N33/532 , G01N33/542 , G01N33/543 , G01N33/16 , G01N31/14
Abstract: A specific binding assay method employing, as a labeling substance, a reversibly binding enzyme modulator for the detection of a ligand in a liquid medium. The method follows conventional specific binding assay techniques of either the homogeneous or heterogeneous type wherein the liquid medium to be assayed is combined with reagent means that includes a labeled conjugate to form a binding reaction system having a bound-species and a free-species of the conjugate. The amount of conjugate resulting in the bound-species or the free-species is a function of the amount of ligand present in the liquid medium assayed. In the present invention, the labeled conjugate comprises a reversibly binding enzyme modulator covalently linked to a binding component of the binding reaction system. The distribution of the conjugate between the bound-species and the free-species is determined by addition of an enzyme whose modulator and measuring the resulting activity of the enzyme. The enzyme modulator may be a conventional enzyme inhibitor, preferably of the competitive type, or an allosteric effector.
-
公开(公告)号:CA1288709C
公开(公告)日:1991-09-10
申请号:CA511592
申请日:1986-06-13
Applicant: MILES LAB
Inventor: CARRICO ROBERT J , PATTERSON WILLIAM L
Abstract: Immobilization of nucleic acids, e.g., DNA and RNA, by contact with a solid support comprising nylon having amide groups that have been derivatized to amidine residues. Derivatization of the nylon support can be accomplished by treatment with an alkylating agent such as a trialkyloxonium salt under anhydrous conditions followed by reaction with an amine. The immobilized nucleic acid is particularly useful as an immobilized probe in hybridization assays to detect specific polynucleotide sequences in a test sample. MS-1422
-
公开(公告)号:CA1288708C
公开(公告)日:1991-09-10
申请号:CA510924
申请日:1986-06-05
Applicant: MILES LAB
Inventor: CARRICO ROBERT J , HATCH ROBERT P , PATTERSON WILLIAM L
Abstract: Immobilization of nucleic acids, e.g., DNA and RNA, by contact with a solid support comprising nylon whose amide groups have been partially solvolyzed. Solvolysis of the nylon support can be accomplished by treatment with an alkylating agent such as a trialkyloxonium salt under anhydrous conditions followed by addition of water. The immobilized nucleic acid is particularly useful as an immobilized probe in hybridization assays to detect specific polynucleotide sequences in a test sample. MS-1419
-
公开(公告)号:CA1239580A
公开(公告)日:1988-07-26
申请号:CA469906
申请日:1984-12-12
Applicant: MILES LAB
Inventor: CARRICO ROBERT J
IPC: C12Q1/68 , G01N20060101 , G01N33/52 , G01N33/53
Abstract: A nucleic acid hybridization assay wherein the hybrid formed with the probe has binding sites for two specific binding reagents, one of which comprises a first label and the other a second label, interaction of the first and second labels providing a detectable response which is measurably different when the two labeled reagents are both bound to the same hybrid compared to when the two labeled reagents are not so bound. The formation of the hybrid assay product brings the two labels within a proximate interaction distance of one another, e.g., as in the cases of sequential catalyst (enzyme) interaction and energy transfer. Since the labels provide a response which is distinguishable when they are associated with a hybridized probe, no separation step is required.
-
-
-
-
-
-
-
-
-